articleCNS Neuroscience & TherapeuticsApr 10, 2013BRONZE OA

Ketamine Pharmacology: An Update ( Pharmacodynamics and Molecular Aspects, Recent Findings )

Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale · Hôpital d'Instruction des Armées Bégin

PubMed
Indexed incrossrefdoajpubmed

Abstract

For more than 50 years, ketamine has proven to be a safe anesthetic drug with potent analgesic properties. The active enantiomer is S(+)-ketamine. Ketamine is mostly metabolized in norketamine, an active metabolite. During "dissociative anesthesia", sensory inputs may reach cortical receiving areas, but fail to be perceived in some association areas. Ketamine also enhances the descending inhibiting serotoninergic pathway and exerts antidepressive effects. Analgesic effects persist for plasma concentrations ten times lower than hypnotic concentrations. Activation of the (N-Methyl-D-Aspartate [NMDA]) receptor plays a fundamental role in long-term potentiation but also in hyperalgesia and opioid-induced…

Citation impact

677
total citations
FWCI
14.17
Percentile
100%
References
152
Citations per year

Authors

2

Topics & keywords

Keywords
  • Ketamine
  • NMDA receptor
  • Pharmacology
  • Analgesic
  • Medicine
  • Opioid
  • Anesthetic
  • Neurotoxicity
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.